Inventor · disambiguated record
Moustafa E. El-Araby
Also filed as: EL-ARABY MOUSTAFA · EL-ARABY MOUSTAFA E · EL-ARABY MOUSTAFA EL-SAYED
32 granted patents·5 pending applications·31 citations·filing 2016–2024
95Inventor score
Files withUNIV KING ABDULAZIZ30UNIV VIRGINIA COMMONWEALTH4ALREEMI ROAA M1BARADWAN MOHAMMED A1UNIV OF JEDDAH1
Top patents by PatentIndex Score
37 records- 0197US10836729B1Metabolically stable 5-HMF derivatives for the treatment of hypoxiaUNIV KING ABDULAZIZ·Filed 2020·Granted Nov 17, 2020·4 cites·4 claims
- 0294US10836736B1Pharmaceutical composition with cytotoxic activity on colorectal cancer cellsUNIV KING ABDULAZIZ·Filed 2020·Granted Nov 17, 2020·7 cites·3 claims
- 0392US11325885B2Method for treating stomach cancerUNIV KING ABDULAZIZ·Filed 2021·Granted May 10, 2022·1 cites·2 claims
- 0491US11214537B2Method for making anti-cancer compoundsUNIV KING ABDULAZIZ·Filed 2021·Granted Jan 4, 2022·1 cites·4 claims
- 0590US11319292B2Metabolically stable 5-HMF derivatives for the treatment of hypoxiaUNIV KING ABDULAZIZ·Filed 2021·Granted May 3, 2022·1 cites·4 claims
- 0690US11136288B2Method for treating a patient having cancerUNIV KING ABDULAZIZ·Filed 2021·Granted Oct 5, 2021·1 cites·7 claims
- 0789US11312680B2Method for treating a patient having a colon cancerUNIV KING ABDULAZIZ·Filed 2021·Granted Apr 26, 2022·1 cites·2 claims
- 0889US11142493B1Pharmaceutical composition for treating cancerUNIV KING ABDULAZIZ·Filed 2021·Granted Oct 12, 2021·1 cites·3 claims
- 0987US11220485B2Chemotherapeutic oxazolone derivatives and pharmaceutical compositions thereofUNIV KING ABDULAZIZ·Filed 2021·Granted Jan 11, 2022·1 cites·3 claims
- 1085US11648248B1Potent antimicrobial compounds with a pyridazine nucleusUNIV KING ABDULAZIZ·Filed 2022·Granted May 16, 2023·3 cites·7 claims
- 1183US11104632B1Metabolically stable vanillin derivatives for the treatment of hypoxiaUNIV KING ABDULAZIZ·Filed 2020·Granted Aug 31, 2021·1 cites·4 claims
- 1283US10844022B1Pharmaceutical composition and method of treating cancerUNIV KING ABDULAZIZ·Filed 2020·Granted Nov 24, 2020·1 cites·2 claims
- 1380US11180458B2Anticancer compounds, pharmaceutical compositions thereof, and a method of treating cancerUNIV KING ABDULAZIZ·Filed 2019·Granted Nov 23, 2021·1 cites·11 claims
- 1480US10988439B2Cytotoxic compounds, pharmaceutical compositions thereof, and methods of treating cancerUNIV KING ABDULAZIZ·Filed 2019·Granted Apr 27, 2021·1 cites·6 claims
- 1580US10882852B13-vinylquinolines as cancer cells inhibitorsUNIV KING ABDULAZIZ·Filed 2020·Granted Jan 5, 2021·1 cites·3 claims
- 1679US12065408B2Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle cell diseaseUNIV VIRGINIA COMMONWEALTH·Filed 2023·Granted Aug 20, 2024·0 cites·11 claims
- 1778US10821096B1Compounds for inhibiting NS3 and compositions containing the inhibited proteinUNIV KING ABDULAZIZ·Filed 2020·Granted Nov 3, 2020·1 cites·5 claims
- 1878US10344001B2Azolylacryloyl derivatives as therapeutic agents for sickle cell diseaseUNIV VIRGINIA COMMONWEALTH·Filed 2016·Granted Jul 9, 2019·3 cites·2 claims
- 1977US11174233B1Anti-cancer compounds having oxazolone derivationUNIV KING ABDULAZIZ·Filed 2021·Granted Nov 16, 2021·0 cites·3 claims
- 2077US10959987B2Imidazole-based compounds as hepatitis C virus inhibitorsUNIV KING ABDULAZIZ·Filed 2019·Granted Mar 30, 2021·1 cites·20 claims
- 2174US11214556B1Method of treating colorectal cancerUNIV KING ABDULAZIZ·Filed 2021·Granted Jan 4, 2022·0 cites·2 claims
- 2274US10844007B1Amide group-containing compounds and use for cancer treatmentUNIV KING ABDULAZIZ·Filed 2020·Granted Nov 24, 2020·0 cites·9 claims
- 2374US2025019349A1Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle cell diseaseUNIV VIRGINIA COMMONWEALTH·Filed 2024·Application pending·0 cites
- 2473US11312694B2Method for making propenamide compoundUNIV KING ABDULAZIZ·Filed 2021·Granted Apr 26, 2022·0 cites·2 claims
- 2569US11155528B2Bis-propenamide compounds and methods of treating cancerUNIV KING ABDULAZIZ·Filed 2019·Granted Oct 26, 2021·0 cites·2 claims
- 2668US11149012B1Metabolically stable 5-HMF derivatives for the treatment of hypoxiaUNIV KING ABDULAZIZ·Filed 2020·Granted Oct 19, 2021·0 cites·2 claims
- 2764US12285418B12-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of acute myeloid leukemiaUNIV OF JEDDAH·Filed 2024·Granted Apr 29, 2025·0 cites·4 claims
- 2864US11345692B13-vinylquinolines as cancer cells inhibitorsUNIV KING ABDULAZIZ·Filed 2020·Granted May 31, 2022·0 cites·10 claims
- 2961US2025282764A1Imidazole heterocycle based compounds and methods of treating cancerUNIV KING ABDULAZIZ·Filed 2024·Application pending·0 cites
- 3061US2024109843A1Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle cell diseaseUNIV VIRGINIA COMMONWEALTH·Filed 2023·Application pending·0 cites
- 3157US2020369727A1Composition and method for treating a patient having liver cirrhosisUNIV KING ABDULAZIZ·Filed 2020·Application pending·0 cites
- 3256US12404246B12-aminomethylimidazole mimics of NS4A and their effect thereof on hepatitis C virus NS3 proteaseBARADWAN MOHAMMED A·Filed 2024·Granted Sep 2, 2025·0 cites·10 claims
- 3355US10842795B1Chemosensitization of resistant Pseudomonas aeruginosa by synthetically related compoundsUNIV KING ABDULAZIZ·Filed 2020·Granted Nov 24, 2020·0 cites·8 claims
- 3454US12258321B1Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancerALREEMI ROAA M·Filed 2024·Granted Mar 25, 2025·0 cites·6 claims
- 3554US2020308228A1Peptide inhibitors of hcv ns3/4a protease comprising non-proteinogenic amino residuesUNIV KING ABDULAZIZ·Filed 2019·Application pending·0 cites
- 3653US11458144B1Methods for using 5-HMF analogs with increased solubility to inhibit or reverse RBC sicklingUNIV KING ABDULAZIZ·Filed 2021·Granted Oct 4, 2022·0 cites·4 claims
- 3748US10894794B1Substituted [1,2,4]triazolo[4,3-a]pyrazines as antidiabeticsUNIV KING ABDULAZIZ·Filed 2019·Granted Jan 19, 2021·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Moustafa E. El-Araby files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →